Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
Hlavní autoři: | Hardman, C, Chen, W, Luo, J, Batty, P, Chen, Y, Nahler, J, Wu, Y, Pavord, I, Erpenbeck, V, Sandham, D, Xue, L, Ogg, G |
---|---|
Médium: | Journal article |
Vydáno: |
Elsevier
2019
|
Podobné jednotky
-
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
Autor: Chen, W, a další
Vydáno: (2018) -
Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
Autor: Xue, L, a další
Vydáno: (2018) -
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
Autor: Sandham, D, a další
Vydáno: (2019) -
Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
Autor: Xue, L, a další
Vydáno: (2019) -
Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells
Autor: Luo, J, a další
Vydáno: (2019)